{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T10:32:12Z","timestamp":1794047532195,"version":"4.8.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,11,12]],"date-time":"2018-11-12T00:00:00Z","timestamp":1541980800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,11,12]],"date-time":"2018-11-12T00:00:00Z","timestamp":1541980800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Ministry of Economy and Competitiveness | Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["Rio Hortega contract (CM16\/0067)"],"award-info":[{"award-number":["Rio Hortega contract (CM16\/0067)"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Ministry of Economy and Competitiveness | Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["Sara Borrell Program (Ref CD14\/00242)"],"award-info":[{"award-number":["Sara Borrell Program (Ref CD14\/00242)"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Non-steroidal anti-inflammatory drugs (NSAIDs)-induced hypersensitivity reactions are classified by the European Network on Drug Allergy (ENDA) as either cross-reactive or selective. The former is the most frequent type and includes patients with exclusively respiratory symptoms (NSAIDs-exacerbated respiratory disease, NERD) or exclusively cutaneous symptoms: NSAIDs-induced urticaria\/angioedema (NIUA); and NSAIDs-exacerbated cutaneous disease (NECD). However, although not reflected in the current classification scheme (ENDA), in clinical practice a combination of both skin and respiratory symptoms or even other organs such as gastrointestinal tract symptoms (mixed or blended reactions) is frequently observed. This entity has not been sufficiently characterised. Our aim was to clinically characterize blended reactions to NSAIDs, comparing their clinical features with NERD and NIUA. We evaluated patients with symptoms suggestive of hypersensitivity to NSAIDs who attended the Allergy Unit of the Regional University Hospital of Malaga (Malaga, Spain) between 2008 and 2015. We included 880 patients confirmed as cross-reactive based on clinical history, positive nasal provocation test with lysine acetylsalicylate (NPT-LASA), and\/or positive drug provocation test (DPT) with acetylsalicylic acid (ASA), who were classified as blended (261; 29.6%), NERD (108; 12.3%) or NIUA (511; 58.1%). We compared symptoms, drugs, underlying diseases and diagnostic methods within and between groups. Among blended patients the most common sub-group comprised those developing urticaria\/angioedema plus rhinitis\/asthma (n\u2009=\u2009138), who had a higher percentage of underlying rhinitis (p\u2009&lt;\u20090.0001) and asthma (p\u2009&lt;\u20090.0001) than NIUA patients, showing similarities to NERD. These differences were not found in the sub-group of blended patients who developed such respiratory symptoms as glottis oedema; these were more similar to NIUA. The percentage of positive NPT-LASA was similar for blended (77%) and NERD groups (78.7%). We conclude that blended reactions are hypersensitivity reactions to NSAIDs affecting at least two organs. In addition to classical skin and respiratory involvement, in our population a number of patients also develop gastrointestinal symptoms. Given the high rate of positive responses to NPT-LASA in NERD as well as blended reactions, we suggest that all patients reporting respiratory symptoms, regardless of whether they have other associated symptoms, should be initially evaluated using NPT-LASA, which poses less risk than DPT.<\/jats:p>","DOI":"10.1038\/s41598-018-34668-1","type":"journal-article","created":{"date-parts":[[2018,11,6]],"date-time":"2018-11-06T12:29:06Z","timestamp":1541507346000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":50,"title":["NSAIDs-hypersensitivity often induces a blended reaction pattern involving multiple organs"],"prefix":"10.1038","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5309-4878","authenticated-orcid":false,"given":"Inmaculada","family":"Do\u00f1a","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"Barrionuevo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda","family":"Salas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Julio","family":"Laguna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9","family":"Ag\u00fandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Garc\u00eda-Mart\u00edn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1868-3471","authenticated-orcid":false,"given":"G\u00e1dor","family":"Bogas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James Richard","family":"Perkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Antonio","family":"Cornejo-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Jos\u00e9","family":"Torres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,11,12]]},"reference":[{"key":"34668_CR1","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1111\/j.1365-2222.2004.02070.x","volume":"34","author":"E Gomes","year":"2004","unstructured":"Gomes, E. et al. Self-reported drug allergy in a general adult Portuguese population. Clin. Exp. Allergy. 34, 1597\u20131601 (2004).","journal-title":"Clin. Exp. Allergy."},{"key":"34668_CR2","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.7326\/0003-4819-140-12-200406150-00009","volume":"140","author":"D Messaad","year":"2004","unstructured":"Messaad, D. et al. Drug provocation tests in patients with a history suggesting an immediate drug hypersensitivity reaction. Ann. Intern. Med. 140, 1001\u20131006 (2004).","journal-title":"Ann. Intern. Med."},{"key":"34668_CR3","first-page":"506","volume":"20","author":"F Chalabianloo","year":"2011","unstructured":"Chalabianloo, F. et al. Clinical characteristics of patients with drug hypersensitivity in Norway: a single-centre study. Pharmacoepidemiology. Drug Saf. 20, 506\u2013513 (2011).","journal-title":"Drug Saf."},{"key":"34668_CR4","first-page":"363","volume":"22","author":"I Do\u00f1a","year":"2012","unstructured":"Do\u00f1a, I. et al. Drug hypersensitivity reactions: response patterns, drug involved, and temporal variations in a large series of patients. J. Investig. Allergol. Clin. Immunology. 22, 363\u2013371 (2012).","journal-title":"J. Investig. Allergol. Clin. Immunology."},{"key":"34668_CR5","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1016\/S0091-6749(96)70102-1","volume":"98","author":"J Quiralte","year":"1996","unstructured":"Quiralte, J., Blanco, C., Castillo, R., Delgado, J. & Carrillo, T. Intolerance to nonsteroidal antiinflammatory drugs: results of controlled drug challenges in 98 patients. J. Allergy Clin. Immunol. 98, 678\u2013685 (1996).","journal-title":"J. Allergy Clin. Immunol."},{"key":"34668_CR6","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/S1081-1206(10)62221-1","volume":"87","author":"DD Stevenson","year":"2001","unstructured":"Stevenson, D. D., Sanchez-Borges, M. & Szczeklik, A. Classification of allergic and pseudoallergic reactions to drugs that inhibit cyclooxygenase enzymes. Ann. Allergy Asthma Immunol. 87, 177\u2013180 (2001).","journal-title":"Ann. Allergy Asthma Immunol."},{"key":"34668_CR7","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1111\/j.1399-3038.2004.00159.x","volume":"15","author":"M Sanchez-Borges","year":"2004","unstructured":"Sanchez-Borges, M., Capriles-Behrens, E. & Caballero-Fonseca, F. Hypersensitivity to non-steroidal anti-inflammatory drugs in childhood. Pediatric Allergy Immunol. 15, 376\u2013380 (2004).","journal-title":"Pediatric Allergy Immunol."},{"key":"34668_CR8","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1159\/000337660","volume":"159","author":"S Caimmi","year":"2012","unstructured":"Caimmi, S., Caimmi, D., Bousquet, P. J. & Demoly, P. How can we better classify NSAID hypersensitivity reactions?\u2013validation from a large database. Int. Arch. Allergy Immunol. 159, 306\u2013312 (2012).","journal-title":"Int. Arch. Allergy Immunol."},{"key":"34668_CR9","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1111\/all.12260","volume":"68","author":"ML Kowalski","year":"2013","unstructured":"Kowalski, M. L. et al. Classification and practical approach to the diagnosis and management of hypersensitivity to nonsteroidal anti-inflammatory drugs. Allergy. 68, 1219\u20131232 (2013).","journal-title":"Allergy."},{"key":"34668_CR10","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1111\/j.1365-2222.2010.03651.x","volume":"41","author":"I Do\u00f1a","year":"2011","unstructured":"Do\u00f1a, I. et al. Characteristics of subjects experiencing hypersensitivity to non-steroidal anti-inflammatory drugs: patterns of response. Clin. Exp. Allergy. 41, 86\u201395 (2011).","journal-title":"Clin. Exp. Allergy."},{"key":"34668_CR11","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1111\/pai.12039","volume":"24","author":"MA Zambonino","year":"2013","unstructured":"Zambonino, M. A. et al. Drug provocation tests in the diagnosis of hypersensitivity reactions to non-steroidal anti-inflammatory drugs in children. Pediatric Allergy Immunol. 24, 151\u2013159 (2013).","journal-title":"Pediatric Allergy Immunol."},{"key":"34668_CR12","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/0091-6749(76)90102-0","volume":"58","author":"A Szczeklik","year":"1976","unstructured":"Szczeklik, A., Gryglewski, R. J., Czerniawska-Mysik, G. & Zmuda, A. Aspirin-induced asthma. Hypersensitivity to fenoprofen and ibuprofen in relation to their inhibitory action on prostaglandin generation by different microsomal enzymic preparations. J. Allergy Clin. Immunol. 58, 10\u201318 (1976).","journal-title":"J. Allergy Clin. Immunol."},{"key":"34668_CR13","doi-asserted-by":"publisher","first-page":"975","DOI":"10.7326\/0003-4819-68-5-975","volume":"68","author":"M Samter","year":"1968","unstructured":"Samter, M. & Beers, R. F. Intolerance to aspirin. Clinical studies and consideration of its pathogenesis. Ann. Intern. Medicine. 68, 975\u2013983 (1968).","journal-title":"Ann. Intern. Medicine."},{"key":"34668_CR14","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1097\/ACI.0b013e32832db943","volume":"9","author":"MG Canto","year":"2009","unstructured":"Canto, M. G., Andreu, I., Fernandez, J. & Blanca, M. Selective immediate hypersensitivity reactions to NSAIDs. Curr. Opin. Allergy Clin. Immunol. 9, 293\u2013297 (2009).","journal-title":"Curr. Opin. Allergy Clin. Immunol."},{"key":"34668_CR15","first-page":"683","volume":"139","author":"WJ Pichler","year":"2003","unstructured":"Pichler, W. J. Delayed drug hypersensitivity reactions. Ann. Intern. Medicine. 139, 683\u2013693 (2003).","journal-title":"Intern. Medicine."},{"key":"34668_CR16","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1111\/pai.12596","volume":"27","author":"M Cousin","year":"2016","unstructured":"Cousin, M., Chiriac, A., Molinari, N., Demoly, P. & Caimmi, D. Phenotypical characterization of children with hypersensitivity reactions to NSAIDs. Pediatric Allergy Immunol. 27, 743\u2013748 (2016).","journal-title":"Pediatric Allergy Immunol."},{"key":"34668_CR17","doi-asserted-by":"publisher","first-page":"e675","DOI":"10.1542\/peds.2005-0969","volume":"116","author":"MI Kidon","year":"2005","unstructured":"Kidon, M. I. et al. Early presentation with angioedema and urticaria in cross-reactive hypersensitivity to nonsteroidal antiinflammatory drugs among young, Asian, atopic children. Pediatrics. 116, e675\u2013680 (2005).","journal-title":"Pediatrics."},{"key":"34668_CR18","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1111\/cea.12013","volume":"43","author":"N Blanca-Lopez","year":"2013","unstructured":"Blanca-Lopez, N. et al. Value of the clinical history in the diagnosis of urticaria\/angioedema induced by NSAIDs with cross-intolerance. Clin. Exp. Allergy. 43, 85\u201391 (2013).","journal-title":"Clin. Exp. Allergy."},{"key":"34668_CR19","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1111\/all.12187","volume":"68","author":"P Campo","year":"2013","unstructured":"Campo, P. et al. Mediator release after nasal aspirin provocation supports different phenotypes in subjects with hypersensitivity reactions to NSAIDs. Allergy. 68, 1001\u20131007 (2013).","journal-title":"Allergy."},{"key":"34668_CR20","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1111\/j.1398-9995.2007.01409.x","volume":"62","author":"E Nizankowska-Mogilnicka","year":"2007","unstructured":"Nizankowska-Mogilnicka, E. et al. EAACI\/GA2LEN guideline: aspirin provocation tests for diagnosis of aspirin hypersensitivity. Allergy. 62, 1111\u20131118 (2007).","journal-title":"Allergy."},{"key":"34668_CR21","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1111\/all.12823","volume":"71","author":"N Blanca-Lopez","year":"2016","unstructured":"Blanca-Lopez, N. et al. ASA must be given to classify multiple NSAID-hypersensitivity patients as selective or cross-intolerant. Allergy. 71, 576\u2013578 (2016).","journal-title":"Allergy."},{"key":"34668_CR22","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1111\/j.1365-2222.2005.2228.x","volume":"35","author":"R Asero","year":"2005","unstructured":"Asero, R. Oral aspirin challenges in patients with a history of intolerance to single non-steroidal anti-inflammatory drugs. Clin. Exp. Allergy. 35, 713\u2013716 (2005).","journal-title":"Clin. Exp. Allergy."},{"key":"34668_CR23","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1016\/j.jaci.2006.07.024","volume":"118","author":"DD Stevenson","year":"2006","unstructured":"Stevenson, D. D. & Szczeklik, A. Clinical and pathologic perspectives on aspirin sensitivity and asthma. J. Allergy Clin. Immunol. 118, 773\u2013786 (2006).","journal-title":"J. Allergy Clin. Immunol."},{"key":"34668_CR24","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1067\/mai.2003.1487","volume":"111","author":"A Szczeklik","year":"2003","unstructured":"Szczeklik, A. & Stevenson, D. D. Aspirin-induced asthma: advances in pathogenesis, diagnosis, and management. J. Allergy Clin. Immunol. 111, 913\u201321 (2003).","journal-title":"J. Allergy Clin. Immunol."},{"key":"34668_CR25","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1111\/j.1398-9995.2011.02684.x","volume":"66","author":"I Do\u00f1a","year":"2011","unstructured":"Do\u00f1a, I. et al. Response to a selective COX-2 inhibitor in patients with urticaria\/angioedema induced by nonsteroidal anti-inflammatory drugs. Allergy. 66, 1428\u20131433 (2011).","journal-title":"Allergy."},{"key":"34668_CR26","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1016\/S1081-1206(10)63166-3","volume":"82","author":"R Asero","year":"1999","unstructured":"Asero, R. Risk factors for acetaminophen and nimesulide intolerance in patients with NSAID-induced skin disorders. Ann. Allergy Asthma Immunol. 82, 554\u2013558 (1999).","journal-title":"Ann. Allergy Asthma Immunol."},{"key":"34668_CR27","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1111\/all.13147","volume":"72","author":"I Do\u00f1a","year":"2017","unstructured":"Do\u00f1a, I. et al. Natural evolution in patients with nonsteroidal anti-inflammatory drug-induced urticaria\/angioedema. Allergy. 72, 1346\u20131355 (2017).","journal-title":"Allergy."},{"key":"34668_CR28","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1111\/all.12335","volume":"69","author":"I Do\u00f1a","year":"2014","unstructured":"Do\u00f1a, I. et al. NSAID-induced urticaria\/angioedema does not evolve into chronic urticaria: a 12-year follow-up study. Allergy. 69, 438\u2013444 (2014).","journal-title":"Allergy."},{"key":"34668_CR29","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1016\/j.mcna.2010.03.005","volume":"94","author":"M Sanchez-Borges","year":"2010","unstructured":"Sanchez-Borges, M. NSAID hypersensitivity (respiratory, cutaneous, and generalized anaphylactic symptoms). Med. Clin. North Am. 94, 853\u2013864 (2010).","journal-title":"Med. Clin. North Am."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-34668-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-34668-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-34668-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T06:40:17Z","timestamp":1671604817000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-34668-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,12]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["34668"],"URL":"https:\/\/doi.org\/10.1038\/s41598-018-34668-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,12]]},"assertion":[{"value":"4 May 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"16710"}}